Methylene blue

What is methylene blue?

Methylene blue is a versatile chemical dye used in both medicine and science. In medicine, the dye methylene blue is an important therapeutic agent for the treatment of methemoglobinemia and is also used as an antidote for nitrite and aniline poisoning. It promotes the conversion of methemoglobin to hemoglobin.

In science, methylene blue is an indispensable staining agent. Its typical blue color is an unmistakable characteristic, as the addition of an alcoholic methylene blue solution causes specific structures to appear blue. It is frequently used in microbiology for cell staining, as well as in molecular biology for staining DNA and RNA. Thanks to its precise staining properties, it is also popular in microscopic examination and water analysis.

It was first used by Paul Ehrlich in 1885 to stain certain types of tissue (particularly gray matter in the peripheral nervous system).

Furthermore, methylene blue serves as a redox indicator in chemical processes. Due to its physicochemical properties, its potential use as a cognitive enhancer is also occasionally discussed.

Summary of the applications of methylene blue:

• Medicine: methemoglobinemia, antidote for poisoning
• Science: cell staining, DNA/RNA staining
• Chemistry: redox indicator

These versatile applications, including as a dietary supplement, show why methylene blue is so highly valued in various fields.

Traditional medical applications

Methylene blue, first synthesized in 1876 by chemist Heinrich Caro as one of the first synthetic dyes, has undergone a remarkable evolution in medicine. Originally conceived as a dye, it soon became apparent that this blue substance also possesses therapeutic properties. Methylene blue has proven to be a life-saving medication, especially in the treatment of methemoglobinemia—a blood disorder in which hemoglobin loses its oxygen-carrying capacity. Furthermore, methylene blue is recognized as a diagnostic agent and is used for the prevention of certain side effects of ifosfamide therapy. These historical applications are an impressive example of the versatility of this chemical substance.

Treatment of malaria

Methylene blue was once used as a medication for the treatment of malaria, one of humanity's most devastating infectious diseases. Before the introduction of more modern drugs like chloroquine, methylene blue was considered a promising treatment option. The chemical compound proved particularly effective against malaria parasites in their gametocyte stage. More recently, methylene blue has been investigated in combination with artesunate or amodiaquine to combat the problem of resistance to conventional malaria drugs. Despite encouraging study results in specific regions where resistance is a significant obstacle, methylene blue-based therapies have not yet received official approval as a malaria medication. Nevertheless, it remains a research focus, as it offers potential for supporting the fight against drug resistance. Its full effect regarding malaria is examined in depth in a comprehensive article in the "Pharmazeutische Zeitung" titled "Ehrlichs Methylenblau - Blauer Farbstoff gegen Malaria" (Ehrlich's Methylene Blue - Blue Dye Against Malaria).

Use in methemoglobinemia

Methylene blue is a highly effective remedy for the rare but dangerous condition methemoglobinemia. This disease can be triggered by contact with nitrates, nitrous gases, or aromatic nitro compounds and leads to the oxidation of the Fe2+ ion in hemoglobin to Fe3+. This oxidized methemoglobin can no longer transport oxygen, a situation that must be treated as quickly as possible. In such cases, methylene blue is used as an injection solution under the trade name methylthioninium chloride Proveblue®. It reduces methemoglobin back to functional hemoglobin, thereby restoring the body's oxygen supply. The use of methylene blue for methemoglobinemia is approved in the EU but must take place strictly under medical supervision to ensure the best possible safety and efficacy of the treatment.

Modern medical applications

Methylene blue, known as methylthioninium chloride, has a multitude of applications in modern medicine. Particularly noteworthy is its role in the treatment of methemoglobinemia, a condition in which oxygen transport in the blood is impaired. Intravenous administration of methylene blue can rapidly improve the condition. The medication is used in this application in the form of the product Proveblue®. It is important that the use of methylene blue occurs under strict medical supervision, as higher doses can cause side effects such as hemolysis. Furthermore, caution must be exercised when simultaneously taking medications that influence serotonin levels, as methylene blue can inhibit the enzyme monoamine oxidase A, which could lead to dangerous interactions. Another interesting area of application is the rediscovery of methylene blue in malaria therapy, especially in times when resistance to other antimalarial drugs is occurring. In the European Union, however, methylene blue is not approved as a food or dietary supplement.

Potential neuroprotective properties

Methylene blue also has promising neuroprotective properties that could make it interesting for the treatment of neurodegenerative diseases. It reduces oxidative stress, which can lead to mitochondrial damage such as that occurring in diseases like Alzheimer's and Parkinson's. As a regenerable antioxidant, methylene blue can neutralize harmful reactive oxygen species (ROS) and thus support mitochondrial health. This ability to reduce oxidative stress contributes to improving the energy supply in the body, thereby unlocking the potential for a general neuroprotective effect. Initial investigations suggest that the intake of methylene blue can support concentration and memory, making it a potential active ingredient in the prevention of neurodegenerative processes.

Memory-enhancing effects

In addition to its neuroprotective properties, methylene blue also has the potential to enhance memory performance. Studies show that low doses of methylene blue can alleviate memory impairments caused by tau fibrils, as evidenced by experiments in mouse models. This makes methylene blue a promising candidate for the optimization of mental performance. It is assumed that the substance helps to improve cognitive performance through its positive influence on mitochondrial function. According to reports, it also leads to increased drive. Although it cannot reverse the progression of memory problems at the cellular level, it is capable of slowing their onset. The correct dosage is crucial here to achieve the desired cognitive improvements without provoking unwanted side effects. These empowering properties of methylene blue could therefore play a significant role in future treatments to preserve cognitive functions in old age.

Effect of methylene blue as "brain doping"

Methylene blue has emerged as a fascinating compound in the field of "brain doping," as it exhibits neuroprotective and memory-enhancing properties at low doses. Methylene blue is particularly popular among biohackers. "Methylene Blue," as it is mostly called in English, is taken by people in social networks and online creators who swear that it can increase and optimize energy and neurological processes.

Many consumers use it to increase cognitive performance. In animal studies with mice, it was shown that methylene blue can help improve memory impairments caused by tau fibrils. In addition, scientists from Göttingen and Bonn have found that methylene blue inactivates molecule groups that strengthen the binding of tau proteins. Another theory states that methylene blue combats mitochondrial oxidative stress and could thus potentially slow brain aging. Nevertheless, research shows that these cognitive benefits have not been clearly proven for existing brain diseases.

Popularity and trends

Methylene blue is not only a popular dye in laboratory applications but is also experiencing an upswing on social media. Platforms like TikTok and YouTube are full of influencers touting methylene blue as a trendy form of brain doping and sharing videos with blue tongues. This popularity originates from the versatile use of methylene blue in the cell culture laboratory and in water analysis. Despite the massive hype, the health benefits of methylene blue as a dietary supplement remain unproven. This harbors risks, especially since medical laypeople may not be able to correctly assess the potential dangers. Uncritical consumption and its dissemination on social media represent a serious problem that should not be neglected.

Safety concerns and side effects

Although methylene blue can be useful in some aspects, there are also serious safety concerns. One of the greatest risks is the potentially fatal serotonin toxicity that can be triggered by methylene blue, as described in the journal *Anaesthesia*. Despite the USP pharmaceutical quality of the product, methylene blue is not approved in the EU as a food or dietary supplement. High doses, starting at approximately 2 mg per kilogram of body weight, can cause side effects such as nausea, vomiting, dizziness, and headaches. Another problem is the unclear quality standards of methylene blue products, which makes their intake risky. The safety of methylene blue in combination with other substances like chloroquine was investigated in studies on G6PD-deficient men and children in Burkina Faso. This shows that cautious consideration of the use of methylene blue is required to avoid unwanted side effects and risks.

Manufacturing and quality assurance

Methylene blue is manufactured and bottled in Germany under strict quality standards. The manufacturing process includes ISO and HACCP certifications, which ensure the highest quality and safety.

The product contains only purified water and 1% methylene blue. It is vegan and free of genetically modified organisms and pollutants.

Independent laboratory analyses confirm the purity of methylene blue, which contains no heavy metals or other impurities. The solution meets USP pharmaceutical quality standards and is produced without the use of formaldehyde.

To ensure quality and durability, the methylene blue solution is packaged in light-protected brown glass bottles with a tamper-evident seal. Furthermore, each bottle contains a pipette for precise dosing.

Summary:

• Ingredients: Purified water, 1% methylene blue
• Packaging: Brown glass bottle, tamper-evident seal, pipette
• Quality standards: ISO, HACCP, USP pharmaceutical quality
• Benefits: Vegan, GMO-free, pollutant-free

These strict quality controls underscore the commitment to offering a highly pure and safe product manufactured according to European standards.

Clinical evidence and research

Methylene blue has been researched intensively over the years to understand and validate its potential therapeutic applications. Originally used to treat malaria, this agent shows promising results in current studies due to its gametocidal effect. Researchers are currently investigating its applicability in combination therapies, especially in areas with drug resistance. In addition to malaria treatment, methylene blue is approved for the treatment of methemoglobinemia and shows specific benefits here. Despite these positive findings, there are areas where further research is required to ensure full efficacy and safety.

Insufficient evidence for efficacy and safety

Although methylene blue is promising in some areas of therapy, there are gaps in the evidence that fully confirm its efficacy and safety. Particularly noteworthy is the treatment of toxic methemoglobinemia, where studies show that efficacy in patients with glucose-6-phosphate dehydrogenase deficiency is insufficiently documented. The combination with chloroquine for malaria treatment also requires more research, as the current data situation is limited. Furthermore, the inhibition of monoamine oxidase A by methylene blue carries a risk of serotonin toxicity, which requires further investigation regarding safety. Finally, methylene blue is not approved in the EU as a food or dietary supplement, which underscores the concerns regarding insufficiently proven safety and efficacy.

Current studies and their results

In recent years, studies on the treatment of malaria have shown progress, particularly in combination therapy with methylene blue. A randomized, controlled study in Burkina Faso was able to document the safety and efficacy of combining methylene blue with artesunate or amodiaquine against uncomplicated *Falciparum* malaria. This combination therapy shows a significant gametocidal effect, which makes it relevant in areas with high drug resistance. Another study confirmed the efficacy of methylene blue as monotherapy in semi-immune adults with uncomplicated *Falciparum* malaria, which further highlights the therapeutic potential of methylene blue.